| Sunil P Pasricha, MD | |
|
3635 S Clyde Morris Blvd, Suite 100, Port Orange, FL 32129-2300 | |
| (386) 788-1242 | |
| (386) 788-4255 |
| Full Name | Sunil P Pasricha |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine - Gastroenterology |
| Location | 3635 S Clyde Morris Blvd, Port Orange, Florida |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1396850152 | NPI | - | NPPES |
| 270352100 | Medicaid | FL |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RG0100X | Internal Medicine - Gastroenterology | ME65464 (Florida) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Sunil P Pasricha, MD 4800 Belfort Rd, Jacksonville, FL 32256-6004 Ph: (904) 398-3262 | Sunil P Pasricha, MD 3635 S Clyde Morris Blvd, Suite 100, Port Orange, FL 32129-2300 Ph: (386) 788-1242 |
News Archive
In a small pilot study, researchers at Brown University, Butler Hospital, and Women & Infants' Hospital have found evidence suggesting that yoga could help pregnant women with significant depression reduce the severity of the mood disorder.
Earlier evidence out of UCLA suggested that meditating for years thickens the brain (in a good way) and strengthens the connections between brain cells. Now a further report by UCLA researchers suggests yet another benefit.
Soligenix, Inc., a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical need, announced today positive results in its Phase 2 clinical trial, in which SGX942, a first-in-class Innate Defense Regulator (IDR), at a dose of 1.5 mg/kg, successfully reduced the median duration of severe oral mucositis by 50% in all patients and by 67% in patients receiving the most aggressive chemoradiation therapy (CRT) for treatment of their head and neck cancer.
Polynoma LLC, a U.S. oncology-focused biopharmaceutical company within Hong Kong-based CK Life Sciences Int'l., today announced the start of a Phase III clinical trial program for POL 103A, the Company's novel melanoma vaccine. Polynoma's global, multi-center, double-blind, placebo-controlled Melanoma Antigen Vaccine Immunotherapy Study (MAVIS) is designed to enroll a total of 1059 patients with resected Stage IIb, IIc or III melanoma.
The Michael J. Fox Foundation for Parkinson's Research announced awards totaling approximately $10.1 million for five new clinical studies and 14 pre-clinical therapeutic development projects. The funding includes $2.5 million to drive four new clinical trials under the Clinical Intervention Awards, one of the Foundation's Edmond J. Safra Core Programs for PD Research.
› Verified 6 days ago
Vrushak Deshpande, M.D. Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 3635 Clyde Morris Blvd Ste 100, Port Orange, FL 32129 Phone: 386-788-1242 Fax: 386-756-8802 | |
Dr. Gregory J. Stella, M.D. Gastroenterology Medicare: Not Enrolled in Medicare Practice Location: 3635 S Clyde Morris Blvd, Ste 100, Port Orange, FL 32129 Phone: 386-788-1242 Fax: 386-788-4255 | |
Souheil Moussly, MD Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 3890 Turtle Creek Dr, Port Orange, FL 32129 Phone: 386-756-4400 Fax: 386-756-3031 | |
Robert Morris Harpold, M.D. Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 3953 S Nova Rd Ste B, Port Orange, FL 32127 Phone: 386-788-4911 Fax: 844-388-6186 | |
Dr. Ashraf S Elsakr, M.D. Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 840 Dunlawton Ave, Ste A, Port Orange, FL 32127 Phone: 386-304-9672 Fax: 386-304-9673 | |
Nikenston Moise, PA Gastroenterology Medicare: Not Enrolled in Medicare Practice Location: 3890 Turtle Creek Dr Ste C, Port Orange, FL 32127 Phone: 386-756-4400 | |
Raxitkumar Jinjuvadia, MD Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 3635 Clyde Morris Blvd Ste 100, Port Orange, FL 32129 Phone: 386-788-1242 Fax: 386-756-8802 |